Moreover, high PLK1 mRNA levels were associated with shorter disease specific survival (DSS) and progression free survival (PFI) in pan-glioma and HGG patients in TCGA dataset (Supplementary Figures 3E, F). This evidence concerns the gene PLK1 and central nervous system cancer.